Penumbra Gains FDA Approval for THUNDERBOLT Thrombectomy System
ALAMEDA, Calif., June 11, 2026 Penumbra, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance...
artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Eli Lilly FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology NSCLC Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
ALAMEDA, Calif., June 11, 2026 Penumbra, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance...
IRVINE, Calif., February 26, 2026 Johnson & Johnson announced the U.S. launch of CEREGLIDEâ„¢ 42, CEREGLIDEâ„¢ 57 aspiration catheters,...
